Identification of Limonol Derivatives as Heat Shock Protein 90 (Hsp90) Inhibitors through a Multidisciplinary Approach.
暂无分享,去创建一个
G. Bifulco | S. Castellano | C. Milite | F. Dal Piaz | A. Vassallo | N. de Tommasi | M. G. Chini | M. Vaccaro | N. Malafronte | A. Leone | Michele Vasaturo | M. Gualtieri | M. Chini | Ciro Milite
[1] P. Workman. Auditing the pharmacological accounts for Hsp90 molecular chaperone inhibitors: unfolding the relationship between pharmacokinetics and pharmacodynamics. , 2003, Molecular cancer therapeutics.
[2] T. Straatsma,et al. THE MISSING TERM IN EFFECTIVE PAIR POTENTIALS , 1987 .
[3] D. Mok,et al. Modulation of Chaperone Function and Cochaperone Interaction by Novobiocin in the C-terminal Domain of Hsp90 , 2006, Journal of Biological Chemistry.
[4] David Siegel,et al. Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition. , 2005, Cancer research.
[5] S. McAlpine,et al. The first report of direct inhibitors that target the C-terminal MEEVD region on heat shock protein 90. , 2016, Chemical communications.
[6] J. Miller,et al. A new cytotoxic limonoid from Odontadenia macrantha from the Suriname rainforest , 2003 .
[7] G. Bifulco,et al. 9H-Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain , 2015, Journal of medicinal chemistry.
[8] L. Elmore,et al. Telomerase as a Target for Cancer Immunotherapy , 2003, Cancer biology & therapy.
[9] K. Takeya,et al. Triterpenoids from Cedrela sinensis , 2005 .
[10] T. Hoye,et al. A guide to small-molecule structure assignment through computation of (1H and 13C) NMR chemical shifts , 2014, Nature Protocols.
[11] Yang Wang,et al. N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes. , 2015, Chemical communications.
[12] Gurulingappa Hallur,et al. Three new tetranortriterpenoids from neem seed oil. , 2002, Journal of natural products.
[13] A. Tosco,et al. Sesterterpenes as tubulin tyrosine ligase inhibitors. First insight of structure-activity relationships and discovery of new lead. , 2009, Journal of medicinal chemistry.
[14] Tao Zhang,et al. A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells , 2008, Molecular Cancer Therapeutics.
[15] S. Arihara,et al. Limonoids and protolimonoids from the fruits of Phellodendron amurense , 1992 .
[16] Giorgio Colombo,et al. Exploiting Conformational Dynamics in Drug Discovery: Design of C-Terminal Inhibitors of Hsp90 with Improved Activities , 2014, J. Chem. Inf. Model..
[17] L. Crawford,et al. Proteasome inhibitors in cancer therapy , 2011, Journal of Cell Communication and Signaling.
[18] J. Buchner,et al. Structural Organization of Procaryotic and Eucaryotic Hsp90. INFLUENCE OF DIVALENT CATIONS ON STRUCTURE AND FUNCTION (*) , 1995, The Journal of Biological Chemistry.
[19] G. Bifulco,et al. Quantum Mechanical Calculation of NMR Parameters in the Stereostructural Determination of Natural Products , 2010 .
[20] Eumorphia G Konstantakou,et al. Targeted inhibition of heat shock protein 90 disrupts multiple oncogenic signaling pathways, thus inducing cell cycle arrest and programmed cell death in human urinary bladder cancer cell lines , 2013, Cancer Cell International.
[21] Woody Sherman,et al. Use of an Induced Fit Receptor Structure in Virtual Screening , 2006, Chemical biology & drug design.
[22] David A. Agard,et al. Intra- and Intermonomer Interactions Are Required to Synergistically Facilitate ATP Hydrolysis in Hsp90*S⃞♦ , 2008, Journal of Biological Chemistry.
[23] K. Anderson,et al. Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma , 2014, Leukemia.
[24] Ta-Wei Lin,et al. The Hexameric Structures of Human Heat Shock Protein 90 , 2011, PloS one.
[25] R. Friesner,et al. Novel procedure for modeling ligand/receptor induced fit effects. , 2006, Journal of medicinal chemistry.
[26] Da-yuan Zhu,et al. Two new pregnanes from Aglaia perviridis Hiern , 2008, Journal of Asian natural products research.
[27] P. Csermely,et al. A Nucleotide-dependent Molecular Switch Controls Atp Binding at the C-terminal Domain of Hsp90 N-terminal Nucleotide Binding Unmasks a C-terminal Binding Pocket* , 2022 .
[28] Anshuman Dixit,et al. Elucidation of the Hsp90 C-terminal inhibitor binding site. , 2011, ACS chemical biology.
[29] G. Bifulco,et al. Computational NMR Methods in the Stereochemical Analysis of Organic Compounds: Are Proton or Carbon NMR Chemical Shift Data More Discriminating? , 2015 .
[30] Y. Morimoto,et al. Rings D-seco and B,D-seco tetranortriterpenoids from root bark of Entandrophragma angolense. , 2011, Phytochemistry.
[31] L. Pearl,et al. Crystal structure of an Hsp90–nucleotide–p23/Sba1 closed chaperone complex , 2006, Nature.
[32] B. Rodriguez. Complete assignments of the 1H and 13C NMR spectra of 15 limonoids , 2003 .
[33] G. Giaccone,et al. Update on Hsp90 inhibitors in clinical trial. , 2009, Current topics in medicinal chemistry.
[34] Harald Schwalbe,et al. Molekularer Mechanismus der Inhibierung des Komplexes aus humanem Hsp90 und humanem Cdc37, einem Kinomchaperon-Cochaperon-System, durch das Triterpen Celastrol† , 2009 .
[35] G. Alexiou,et al. The role of heat shock proteins in cancer. , 2015, Cancer letters.
[36] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[37] J. Nuzillard,et al. Delevoyin C, a tetranortriterpenoid from Entandrophragma delevoyi. , 2000, Phytochemistry.
[38] O. Zerbe,et al. New mosquito larvicidal tetranortriterpenoids from Turraea wakefieldii and Turraea floribunda. , 2004, Journal of agricultural and food chemistry.
[39] Erin E. Carlson,et al. Natural products as chemical probes. , 2010, ACS chemical biology.
[40] T. Golub,et al. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. , 2006, Cancer cell.
[41] A. Roy,et al. Limonoids: overview of significant bioactive triterpenes distributed in plants kingdom. , 2006, Biological & pharmaceutical bulletin.
[42] Y. Morimoto,et al. Limonoids from the stem bark of Cedrela odorata. , 2008, Phytochemistry.
[43] S. Abdelgaleil,et al. Phragmalin limonoids from Chukrasia tabularis. , 2004, Phytochemistry.
[44] Limonoids from Cedrela sinensis. , 2004, Phytochemistry.
[45] G. D. Manners. Citrus limonoids: analysis, bioactivity, and biomedical prospects. , 2007, Journal of agricultural and food chemistry.
[46] M. Nakatani,et al. Swietenialides, novel ring D opened phragmalin limonoid orthoesters from Swietenia mahogani JACQ. , 2003 .
[47] Giuseppe Bifulco,et al. Comparison of different theory models and basis sets in the calculation of 13C NMR chemical shifts of natural products , 2004, Magnetic resonance in chemistry : MRC.
[48] G. Bifulco,et al. Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold. , 2015, Chemical communications.
[49] G. Colombo,et al. Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors. , 2015, European journal of medicinal chemistry.
[50] H. Schwalbe,et al. Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by triterpene celastrol. , 2009, Angewandte Chemie.
[51] Giuseppe Bifulco,et al. Determination of relative configuration in organic compounds by NMR spectroscopy and computational methods. , 2007, Chemical reviews.
[52] S. Terracciano,et al. Hsp90 Activity Modulation by Plant Secondary Metabolites , 2015, Planta Medica.
[53] J. Reinstein,et al. C-terminal regions of Hsp90 are important for trapping the nucleotide during the ATPase cycle. , 2000, Journal of molecular biology.
[54] J. Fernandes,et al. Androstane and pregnane 2β,19-hemiketal steroids from Trichilia claussenii , 1997 .
[55] Hong Zhang,et al. Targeting multiple signal transduction pathways through inhibition of Hsp90 , 2004, Journal of Molecular Medicine.
[56] R. Wong,et al. LC-MS and NMR Techniques for the Analysis and Characterization ofCitrusLimonoids , 2000 .
[57] J. D. Connolly,et al. Tetranortriterpenoids—VII : [Bicyclononanolides—V] the constitution and stereochemistry of swietenolide , 1968 .
[58] I Nicoletti,et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.
[59] T. Gasiewicz,et al. (-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor. , 2009, Biochemistry.
[60] Paul Workman,et al. Hsp90 Molecular Chaperone Inhibitors: Are We There Yet? , 2012, Clinical Cancer Research.
[61] C. Fan,et al. Cytotoxic Terpenoids from Turraea pubescens , 2008 .
[62] G. Bifulco,et al. A chemical-biological study reveals C9-type iridoids as novel heat shock protein 90 (Hsp90) inhibitors. , 2013, Journal of medicinal chemistry.
[63] M. Simmonds,et al. Citrus limonoids and their semisynthetic derivatives as antifeedant agents against Spodoptera frugiperda larvae. A structure-activity relationship study. , 2002, Journal of agricultural and food chemistry.
[64] G. Bifulco,et al. Structural characterization of tetranortriterpenes from Pseudrocedrela kotschyi and Trichilia emetica and study of their activity towards the chaperone Hsp90. , 2012, Phytochemistry.
[65] J. Buchner,et al. Transient Interaction of Hsp90 with Early Unfolding Intermediates of Citrate Synthase , 1995, The Journal of Biological Chemistry.